Enzo Biochem (ENZ)
(Delayed Data from NYSE)
$1.11 USD
+0.02 (1.84%)
Updated May 20, 2024 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Enzo Biochem, Inc. [ENZ]
Reports for Purchase
Showing records 21 - 40 ( 55 total )
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
US Supreme Court Delivers an Important Victory Potential Upside in the Long Run
Provider: RODMAN & RENSHAW, CO.
Analyst: NOCHOMOVITZ Y
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
US Supreme Court Delivers an Important Victory - Potential Upside in the Long Run
Provider: RODMAN & RENSHAW, CO.
Analyst: NOCHOMOVITZ Y
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
LAB REVENUES EXCEED OUR ESTIMATES - COLONSENTRY APPROVAL A KEY DRIVER
Provider: RODMAN & RENSHAW, CO.
Analyst: NOCHOMOVITZ Y
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
LAB REVENUES EXCEED OUR ESTIMATES - COLONSENTRY APPROVAL A KEY DRIVER
Provider: RODMAN & RENSHAW, CO.
Analyst: NOCHOMOVITZ Y
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
Approval of ColoVantage in New York State Bodes Well for Enzos ColonSentry Application
Provider: RODMAN & RENSHAW, CO.
Analyst: NOCHOMOVITZ Y
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
Approval of ColoVantage in New York State Bodes Well for Enzos ColonSentry Application
Provider: RODMAN & RENSHAW, CO.
Analyst: NOCHOMOVITZ Y
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
REVENUE GROWTH RATE SLOWER THAN ANTICIPATED - LOWERING TARGET
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
REVENUE GROWTH RATE SLOWER THAN ANTICIPATED - LOWERING TARGET
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
2010 RECAP & 2011 PREVIEW
Provider: RODMAN & RENSHAW, CO.
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
COLON SENTRY SUBMITTED TO NY STATE - POTENTIAL FOR LAUNCH IN MID-2011
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
CONTROLLING CASH USAGE AND MOVING TO CASH FLOW POSITIVE IN 2011
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
Lab Industry Alert: Attending 28th Annual Lab Institute 2010 Conference.
Provider: KAUFMAN BROTHERS
Analyst: BROCK D
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
Optiquel Enters the Clinic for Autoimmune Uveitis - Supports Biotech Upside
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY.
Provider: RODMAN & RENSHAW, CO.
Company: Enzo Biochem, Inc.
Industry: Medical - Biomedical and Genetics
In Today''s Morning Exchange
Provider: KAUFMAN BROTHERS